AKT1 and pulmonary fibrosis: Mounting evidence revealed that PI3K/Akt signaling-mediated-inflammation may be responsible for various fibrosis diseases, including lung fibrosis [31, 53, 54], liver fibrosis [55], and intestinal fibrosis [56].